| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | 128 | 128 |
| - | - | - | - | - | - | - | - | - | 6 | 6 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| 4 | - | - | - | - | - | - | 4 |
| 29 | 1 | - | - | - | - | - | 30 |
| AME |
|---|
| - |
| - |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| - |
| - |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(R) | 128 | 87.7% | -4.42 | 6 | 15.4% |
| LO(R) | 4 | 2.7% | 2.91 | 30 | 76.9% |
| Optic-unspecified(R) | 14 | 9.6% | -2.22 | 3 | 7.7% |
| upstream partner | # | NT | conns T4_unclear | % In | CV |
|---|---|---|---|---|---|
| Mi1 (R) | 8 | ACh | 54 | 37.5% | 0.8 |
| Mi9 (R) | 5 | Glu | 38 | 26.4% | 0.9 |
| TmY15 (R) | 3 | GABA | 13 | 9.0% | 0.8 |
| T4c (R) | 5 | ACh | 11 | 7.6% | 0.5 |
| Tm3 (R) | 2 | ACh | 7 | 4.9% | 0.1 |
| CT1 (L) | 1 | GABA | 6 | 4.2% | 0.0 |
| Tlp12 (R) | 1 | Glu | 4 | 2.8% | 0.0 |
| Mi4 (R) | 2 | GABA | 4 | 2.8% | 0.0 |
| T5c (R) | 1 | ACh | 1 | 0.7% | 0.0 |
| C3 (R) | 1 | GABA | 1 | 0.7% | 0.0 |
| T4b (R) | 1 | ACh | 1 | 0.7% | 0.0 |
| TmY5a (R) | 1 | Glu | 1 | 0.7% | 0.0 |
| Y11 (R) | 1 | Glu | 1 | 0.7% | 0.0 |
| Pm10 (R) | 1 | GABA | 1 | 0.7% | 0.0 |
| OA-AL2i1 (R) | 1 | unc | 1 | 0.7% | 0.0 |
| downstream partner | # | NT | conns T4_unclear | % Out | CV |
|---|---|---|---|---|---|
| T5c (R) | 5 | ACh | 39 | 26.7% | 0.5 |
| TmY15 (R) | 2 | GABA | 16 | 11.0% | 0.5 |
| CT1 (L) | 1 | GABA | 14 | 9.6% | 0.0 |
| Tm5Y (R) | 2 | ACh | 11 | 7.5% | 0.6 |
| LT33 (L) | 1 | GABA | 6 | 4.1% | 0.0 |
| LC4 (R) | 1 | ACh | 6 | 4.1% | 0.0 |
| T5b (R) | 2 | ACh | 6 | 4.1% | 0.7 |
| T5a (R) | 2 | ACh | 6 | 4.1% | 0.3 |
| Tm1 (R) | 4 | ACh | 6 | 4.1% | 0.3 |
| T5d (R) | 3 | ACh | 5 | 3.4% | 0.6 |
| T2a (R) | 1 | ACh | 4 | 2.7% | 0.0 |
| T4c (R) | 3 | ACh | 4 | 2.7% | 0.4 |
| Tm4 (R) | 2 | ACh | 3 | 2.1% | 0.3 |
| T4d (R) | 3 | ACh | 3 | 2.1% | 0.0 |
| TmY9a (R) | 1 | ACh | 2 | 1.4% | 0.0 |
| T4a (R) | 1 | ACh | 1 | 0.7% | 0.0 |
| Tm29 (R) | 1 | Glu | 1 | 0.7% | 0.0 |
| Mi9 (R) | 1 | Glu | 1 | 0.7% | 0.0 |
| Tm2 (R) | 1 | ACh | 1 | 0.7% | 0.0 |
| Tm3 (R) | 1 | ACh | 1 | 0.7% | 0.0 |
| T3 (R) | 1 | ACh | 1 | 0.7% | 0.0 |
| TmY9b (R) | 1 | ACh | 1 | 0.7% | 0.0 |
| T2 (R) | 1 | ACh | 1 | 0.7% | 0.0 |
| LC10a (R) | 1 | ACh | 1 | 0.7% | 0.0 |
| TmY4 (R) | 1 | ACh | 1 | 0.7% | 0.0 |
| LC10_unclear (R) | 1 | ACh | 1 | 0.7% | 0.0 |
| Y11 (R) | 1 | Glu | 1 | 0.7% | 0.0 |
| Tm23 (R) | 1 | GABA | 1 | 0.7% | 0.0 |
| Pm10 (R) | 1 | GABA | 1 | 0.7% | 0.0 |
| OA-AL2i1 (R) | 1 | unc | 1 | 0.7% | 0.0 |